Ignite Creation Date:
2024-07-17 @ 10:46 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06498921
Status:
COMPLETED
Last Update Posted:
2024-07-12
First Post:
2024-07-05
Brief Title:
An Observational Study to Learn More About the Use of Darolutamide as a Part of a Combination Therapy in Belgian Men With Metastatic Hormone-Sensitive Prostate Cancer in Routine Medical Care
Sponsor:
Organization:
Bayer